We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on a vaccination strategy to control the ongoing polio incident.
Statement updating the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 vaccination programme for autumn 2023.
An interim statement from the Joint Committee on Vaccination and Immunisation (JCVI) on changes to the childhood immunisation schedule.
The Joint Committee on Vaccination and Immunisation's (JCVI) interim advice on a one-dose schedule for the human papillomavirus (HPV) immunisation programme.
The Joint Committee on Vaccination and Immunisation's (JCVI) concluding advice on a one-dose schedule for the human papillomavirus (HPV) immunisation programme.
A statement from the Joint Committee on Vaccination and Immunisation on the meningococcal vaccination.
Statement setting out the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 vaccination programme for autumn 2023.
Sets out JCVI consideration on the number of doses of flu (influenza) vaccine that should be offered to children.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) in response to the emergence of the Omicron variant.
Using the nasal spray flu vaccine for the UK childhood influenza immunisation programme: advice from JCVI
JCVI position statement on the use of meningococcal B (MenB) vaccine in the UK.
Statement setting out the latest advice from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccines for autumn 2022.
Evidence and considerations for extending the HPV vaccination programme to adolescent boys, from the Joint Committee on Vaccination and Immunisation’s (JCVI).
The Joint Committee on Vaccination and Immunisation's (JCVI) statement on delivery of the human papillomavirus (HPV) programme in light of school closures associated with coronavirus (COVID-19).
For 2022, the primary aim of the COVID-19 vaccination programme continues to be the prevention of severe disease (hospitalisation and mortality) arising from COVID-19.
The Joint Committee on Vaccination and Immunisation's (JCVI) final recommendations on changes to the childhood immunisation schedule.
An interim position statement about the use of Bexsero meningococcal B vaccine in the UK released by JCVI.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).